Navigation Links
Johns Hopkins experts to present genetics advances at international meeting this weekend
Date:4/12/2013

Johns Hopkins genetics researchers Aravinda Chakravarti, Ph.D., and David Valle, M.D., will each present at the joint conference of the Human Genome Meeting 2013 and the 21st International Congress of Genetics. The conference, which will take place in Singapore April 13-18, 2013, will focus on the genetics and genomics of world health and sustainability. Chakravarti and Valle are the former and current director, respectively, of the Johns Hopkins University McKusick-Nathans Institute of Genetic Medicine.

Both Chakravarti and Valle will speak at the conference's "Mendelian Genetic Diseases" session, to be held on April 13 from 10 a.m. to 12 p.m. local time. Chakravarti will relate his findings about Hirschsprung's disease, an inherited intestinal disorder that, he has found, can be caused by a number of different rare genetic variations. Valle will speak about the work of the Baylor-Johns Hopkins Center for Mendelian Genetics, a four-year, National Institutes of Health-funded search for the culprits behind single-gene diseases usually called Mendelian disorders.

On April 18 at 8:30 a.m., Chakravarti will chair a plenary discussion in which he will reflect on progress in genomics since the sequencing of the human genome 10 years ago, focusing on the areas of ethical issues, identifying disease genes and understanding gene mechanisms. Related stories:

Chakravarti:

Genome-Wide Hunts Reveal New Regulators of Blood Pressure: http://www.hopkinsmedicine.org/news/media/releases/genome_wide_hunts_reveal_new_regulators_of_blood_pressure

The 1,000 Genomes Project: http://www.hopkinsmedicine.org/geneticmedicine/news/NewsletterStories/2010_12/2010_12_1000_genomes.html

Teasing Apart the Genetics of a Complex Disorder: http://www.hopkinsmedicine.org/geneticmedicine/news/NewsletterStories/2010_09/2010_09_Aravinda.html

New Genes Implicated in High Blood Pressure: http://www.hopkinsmedicine.org/news/media/releases/New_Genes_Implicated_in_High_Blood_Pressure

Big Man in Genes: http://www.hopkinsmedicine.org/hmn/W02/top.html

Valle:

Individualized Medicine Comes to Johns Hopkins: http://www.hopkinsmedicine.org/geneticmedicine/news/NewsletterStories/2009_03/2009_03_feature.html

Johns Hopkins Researchers Discover New Schizophrenia Gene: http://m.hopkinsmedicine.org/news/media/releases/Johns_Hopkins_Researchers_Discover_New_Schizophrenia_Gene

The Johns Hopkins Center for Inherited Disease Research Receives $101 Million: http://m.hopkinsmedicine.org/news/media/releases/the_johns_hopkins_center_for_inherited_disease_research_receives_101_million

New Database to Speed Genetic Discoveries: http://www.hopkinsmedicine.org/news/media/releases/new_database_to_speed_genetic_discoveries


'/>"/>

Contact: Shawna Williams
shawna@jhmi.edu
410-955-8236
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Johnson & Johnson Ethicon Transvaginal Mesh Lawsuits Update: Resource4thePeople Reports Judge Schedules More Trials for This Summer
2. Carey Danis & Lowe Optimistic About DePuy ASR Hip Lawsuits Following Johnson & Johnson Loss
3. Sun Yat-sen University and Johns Hopkins sign collaboration agreement
4. US Drug Watchdog Now Urges Any Woman Who had A Out Of The Blue Stroke Or Heart Attack After Using Birth Control Pills Call Yaz, Or Yasmin to Call the Johnson Law Group
5. US Drug Watchdog Now Urges Families Of Diabetics Who Developed Bladder Cancer After Using The Diabetes Drug Called To Call The Johnson Law Group-For A Legal Review
6. Los Angeles Personal Injury Attorney Jeff Nadrich Responds to News that Johnson & Johnson Inadequately Assessed Metal Hip Dangers
7. Johns Hopkins Medicine expands reach in Latin America
8. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and Had a Heart Attack or Stroke As Far Back As 2005 to Call The Johnson Law Group-Nationwide
9. US Drug Watchdog Now Urges All Diabetics Nationwide Who Used the Diabetes Drug Actos and now have Bladder Cancer to Call The Johnson Law Group For A Legal Evaluation
10. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills and Had a Heart Attack or Stroke in 2008, or 2009 to Call The Johnson Law Group-Before Time Runs Out
11. US Drug Watchdog Now Urges Diabetics Who Used the Diabetes Drug Actos and Then Developed Bladder Cancer to Call the Johnson Law Group for a Legal Review - Get Compensated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Medforce Technologies, a leading ... the only electronic signature tool built specifically for the healthcare industry by a ... in the modern healthcare company: obtaining signatures from a wide variety of individuals ...
(Date:2/28/2017)... Gowrie, IA (PRWEB) , ... February 28, 2017 , ... Webster-Calhoun Cooperative Telephone Association ... cooperative to be held on Tuesday, March 14th at 7:00 pm at the Southeast Valley ... is "Set Your Sights For Great Service" What do you look for in ...
(Date:2/28/2017)... ... February 28, 2017 , ... Today, Bright Pink , a national ... empowering young women to live proactively at a young age. 1 in 8 ... cancer. Prevention and early detection can save lives-but only if young women are proactive ...
(Date:2/28/2017)... ... February 28, 2017 , ... The American Academy of ... scientific development, healthcare training and clinical application of medical infrared imaging, has announced ... 16-17 in Greenville, SC at the Bon Secours St. Francis Hospital campus at ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... Institute (HCI) announced a new partnership through which HCI students, faculty, and ... curriculum and practices. The partnership also enables the HCI community to receive educational ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... February 28, 2017 The ... rendered the vendor landscape of the  Global Lap ... exhibits a high degree of consolidation with the ... the overall market in 2016. Among these enterprises ... and Abbott Laboratories enjoy dominance on account of ...
(Date:2/28/2017)... Calif., Feb. 28, 2017  Ionis Pharmaceuticals, Inc. (Nasdaq: ... its financial guidance by ending 2016 with pro forma ... cash, cash equivalents and short-term investments. The Company also ... "2016 was a year of significant accomplishments ... in record time and with a very broad label. ...
(Date:2/28/2017)... 28, 2017 ... Research and Markets has announced the addition of the ... to their offering. The latest research Ovarian Cancer Drugs ... in the global Ovarian Cancer market. The research answers the ... marketed for Ovarian Cancer and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: